Susan Resnick, PhD
Susan Resnick, PhD, brings more than 20 years of experience in clinical research, medical device technology, and regulatory strategy to 3D clients. Susan uses her extensive experience to guide 3D’s clients through critical pre-IDE and pre-PMA meetings with FDA, as well as help them prepare for FDA advisory committee meetings. In her role as a scientific lead for 3D clients, Susan provides strategic review of clinical study reports, briefing books, and panel packs. Before joining 3D, Susan held a variety of clinical research leadership positions at Boston Scientific and Medtronic, working on teams going through the approval process. She has published more than 35 manuscripts in peer review medical journals. Susan has a Master’s of Public Health and PhD in Epidemiology from the University of Minnesota.